peroxiredoxin 3 | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

35,973 results for “peroxiredoxin 3”

New Drug RSO-021 Shows Promise in Mesothelioma Trial by Targeting Cancer's Energy System

PRDX6 Enzyme Inhibition Shows Promise in Neuroblastoma Treatment

VASTHERA Receives FDA Clearance for Phase 1 Trial of Novel PAH Drug VTB-10

Pulmonary Arterial Hypertension Pipeline Expands with 55+ Therapies as Merck's WINREVAIR Shows 76% Mortality Risk Reduction

Sanofi's Rilzabrutinib Achieves Primary Endpoint in Phase 3 ITP Trial

LAG-3 Inhibitors Show Promise in Cancer Immunotherapy, Market Expected to Surge

Diamyd Medical's Diagnode-3 Phase 3 Trial Reaches Recruitment Target

Atea's Bemnifosbuvir Fails to Meet Primary Endpoint in Phase 3 COVID-19 Trial

Vera Therapeutics Completes Enrollment for Atacicept Phase 3 ORIGIN 3 Trial in IgAN

Amgen's Rocatinlimab and Uplizna Phase 3 Data Impact Stock

Page 1 of 1224